# TMTP1-ICG Mapping in Colposcopy-directed Biopsy

> **NCT03321461** · PHASE1 · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 40 (estimated)

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** TMTP1
- **DRUG:** ICG

## Key facts

- **NCT ID:** NCT03321461
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2021-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321461, "TMTP1-ICG Mapping in Colposcopy-directed Biopsy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03321461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*